رجوع
مُدرج أيضًا باسم
SMDPY
OTC
نطاق اليوم
KWD 13.36
KWD 14.29
نطاق 52 أسبوعًا
KWD 4.00
KWD 19.20
حجم التداول
801
متوسط 50 يوم / 200 يوم
KWD 14.11
/
KWD 11.50
الإغلاق السابق
KWD 13.36
Quick Summary
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (631 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 0.2 | 0.3 |
| P/B | 0.0 | 3.0 |
| ROE % | 14.5 | 3.7 |
| Net Margin % | 5.9 | 3.8 |
| Rev Growth 5Y % | -6.2 | 10.0 |
| D/E | 1.8 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 243.04
KWD 219.63 – KWD 271.16
|
575.89B | 1 |
| FY2029 |
KWD 189.80
KWD 171.51 – KWD 211.75
|
524.09B | 1 |
| FY2028 |
KWD 219.11
KWD 198.00 – KWD 244.46
|
560.31B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-01-30 | -KWD 0.87 | KWD 0.14 | +116.3% |
| 2025-06-30 | KWD 0.14 | KWD 0.19 | +42.4% |
| 2025-03-31 | -KWD 0.08 | KWD 0.04 | +150.9% |
| 2024-12-31 | KWD 0.26 | KWD 0.86 | +225.5% |
| 2024-09-30 | KWD 0.12 | -KWD 0.82 | -753.2% |
| 2024-06-29 | -KWD 0.07 | KWD 0.25 | +480.7% |
| 2024-03-30 | -KWD 2.14 | -KWD 3.27 | -52.9% |
| 2023-12-31 | -KWD 0.41 | -KWD 0.90 | -119.1% |
Dividend History
Yield
0.00%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 30, 2023 | Jun 28, 2023 | KWD 0.05 | 2.34% |
| Sep 29, 2022 | Dec 01, 2022 | KWD 0.10 | 2.57% |
| Mar 30, 2022 | Jun 24, 2022 | KWD 0.11 | 2.35% |
| Sep 29, 2021 | Dec 01, 2021 | KWD 0.13 | 1.54% |
| Mar 30, 2021 | Jun 25, 2021 | KWD 0.13 | 1.39% |
| Sep 29, 2020 | Dec 01, 2020 | KWD 0.13 | 1.94% |
| Mar 30, 2020 | Jun 24, 2020 | KWD 0.13 | 1.98% |
| Sep 27, 2019 | Dec 02, 2019 | KWD 0.13 | 12.56% |
| Mar 27, 2019 | Jun 21, 2019 | KWD 2.00 | 7.94% |
| Sep 26, 2018 | Dec 03, 2018 | KWD 0.08 | 1.13% |
| Mar 28, 2018 | Jun 20, 2018 | KWD 0.18 | 1.73% |
| Sep 27, 2017 | Dec 01, 2017 | KWD 0.08 | 1.24% |
| Mar 29, 2017 | Jun 23, 2017 | KWD 0.08 | 54.70% |
| Sep 28, 2016 | — | KWD 9.00 | 47.29% |
| Mar 29, 2016 | — | KWD 0.08 | 1.42% |
| Sep 28, 2015 | — | KWD 0.08 | 1.45% |
| Mar 27, 2015 | — | KWD 0.08 | 1.59% |
| Sep 26, 2014 | — | KWD 0.08 | 1.32% |
| Mar 27, 2014 | — | KWD 0.09 | 55.45% |
| Sep 26, 2013 | — | KWD 9.00 | 139.64% |
النقاط الرئيسية
Revenue declined -6.23% annually over 5 years
ROE of 14.52% — decent returns on equity
Generating 3.47B in free cash flow
P/E of 0.22 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 33.02%
Capital efficient — spends only 3.27% of revenue on capex
النمو
Revenue Growth (5Y)
-6.23%
Revenue (1Y)26.79%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
14.52%
ROIC2.36%
Net Margin5.93%
Op. Margin3.74%
الأمان
Debt / Equity
1.80
Current Ratio1.05
Interest Coverage1.11
التقييم
P/E Ratio
0.22
Forward P/EN/A
P/B Ratio0.03
EV/EBITDA19.27
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 26.79% | Revenue Growth (3Y) | -15.27% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -6.23% | Earnings Growth (5Y) | -19.48% |
| Profitability | |||
| Revenue (TTM) | 398.83B | Net Income (TTM) | 23.63B |
| ROE | 14.52% | ROA | 3.18% |
| Gross Margin | 61.53% | Operating Margin | 3.74% |
| Net Margin | 5.93% | Free Cash Flow (TTM) | 3.47B |
| ROIC | 2.36% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1.80 | Current Ratio | 1.05 |
| Interest Coverage | 1.11 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 0.22 | Forward P/E | N/A |
| P/B Ratio | 0.03 | P/S Ratio | 0.01 |
| PEG Ratio | -0.11 | Forward PEG | N/A |
| EV/EBITDA | 19.27 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 65.38% | ||
| Market Cap | 5.31B | Enterprise Value | 287.61B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 398.83B | 314.56B | 555.54B | 560.04B | 515.95B |
| Net Income | 23.63B | -314.97B | -74.51B | 56.41B | 56.22B |
| EPS (Diluted) | 59.49 | -792.79 | -187.55 | 141.99 | 141.50 |
| Gross Profit | 245.40B | 187.98B | 376.63B | 402.91B | 378.18B |
| Operating Income | 14.93B | -354.86B | -76.98B | 60.23B | 71.22B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 742.60B | 907.51B | 1.13T | 1.31T | 1.31T |
| Total Liabilities | 573.13B | 751.37B | 727.96B | 634.44B | 659.95B |
| Shareholders' Equity | 169.48B | 156.06B | 406.75B | 607.89B | 580.57B |
| Total Debt | 305.42B | 427.86B | 334.72B | 269.05B | 273.82B |
| Cash & Equivalents | 23.12B | 29.05B | 143.48B | 202.98B | 193.70B |
| Current Assets | 253.17B | 269.57B | 381.86B | 499.52B | 459.80B |
| Current Liabilities | 240.60B | 515.47B | 372.69B | 278.37B | 278.15B |